{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:08:04Z","timestamp":1790662084890,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","award":["KFOC 150004"],"award-info":[{"award-number":["KFOC 150004"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1053\/j.ajkd.2022.04.005","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T04:03:42Z","timestamp":1654056222000},"page":"740-750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases"],"prefix":"10.1053","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4308-3083","authenticated-orcid":false,"given":"Mark","family":"Canney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Gunning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caren","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arenn","family":"Jauhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Am","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahat","family":"Sahota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather N.","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Barbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9731","key":"10.1053\/j.ajkd.2022.04.005_bib1","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"10.1053\/j.ajkd.2022.04.005_bib2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ki.2010.536","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality: a collaborative meta-analysis of high-risk population cohorts","volume":"79","author":"Van der Velde","year":"2011","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2022.04.005_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000133312.96477.48","article-title":"Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes","volume":"110","author":"Klausen","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.ajkd.2022.04.005_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0272-6386(12)80994-2","article-title":"Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment","volume":"23","author":"Wheeler","year":"1994","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2022.04.005_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0272-6386(12)70179-8","article-title":"The nephrotic syndrome, lipids, and risk factors for cardiovascular disease","volume":"22","author":"Radhakrishnan","year":"1993","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2022.04.005_bib6","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/art.22568","article-title":"Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus","volume":"56","author":"Westerweel","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1053\/j.ajkd.2022.04.005_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.berh.2012.12.004","article-title":"Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides","volume":"27","author":"Cohen Tervaert","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"10.1053\/j.ajkd.2022.04.005_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.semarthrit.2017.07.004","article-title":"The BVAS is an independent predictor of cardiovascular events and cardiovascular disease-related mortality in patients with ANCA-associated vasculitis: a study of 504 cases in a single Chinese center","volume":"47","author":"Bai","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1053\/j.ajkd.2022.04.005_bib9","doi-asserted-by":"crossref","first-page":"c40","DOI":"10.1159\/000135632","article-title":"Endothelial function in patients with proteinuric primary glomerulonephritis","volume":"109","author":"Mackinnon","year":"2008","journal-title":"Nephron Clin Pract"},{"issue":"2","key":"10.1053\/j.ajkd.2022.04.005_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/art.23352","article-title":"Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?","volume":"59","author":"Karp","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1053\/j.ajkd.2022.04.005_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1432-2277.2010.01140.x","article-title":"Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors: an opportunity to improve cardiovascular risk following kidney transplantation?","volume":"24","author":"Zeier","year":"2011","journal-title":"Transplant Int"},{"issue":"7","key":"10.1053\/j.ajkd.2022.04.005_bib12","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/ndt\/gfl062","article-title":"Vascular diseases and their risk factors in IgA nephropathy","volume":"21","author":"Myllymaki","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2022.04.005_bib13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","article-title":"High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study","volume":"117","author":"Mahmoodi","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1053\/j.ajkd.2022.04.005_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.kint.2015.12.041","article-title":"Patients with primary membranous nephropathy are at high risk of cardiovascular events","volume":"89","author":"Lee","year":"2016","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2022.04.005_bib15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.1993.292","article-title":"The increased risk of coronary heart disease associated with nephrotic syndrome","volume":"44","author":"Ordo\u00f1ez","year":"1993","journal-title":"Kidney Int"},{"issue":"8","key":"10.1053\/j.ajkd.2022.04.005_bib16","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/ndt\/14.8.1889","article-title":"The epidemiology and prognosis of glomerulonephritis in Denmark 1985-1997","volume":"14","author":"Heaf","year":"1999","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2022.04.005_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12882-017-0511-z","volume":"18","author":"Hutton","year":"2017","journal-title":"BMC Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2022.04.005_bib18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/eurheartj\/ehy422","article-title":"Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis","volume":"40","author":"O\u2019Shaughnessy","year":"2019","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1053\/j.ajkd.2022.04.005_bib19","first-page":"259","article-title":"KDIGO 2013 clinical practice guideline for lipid management in chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"10.1053\/j.ajkd.2022.04.005_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2215\/CJN.08060719","article-title":"Socioeconomic position and incidence of glomerular diseases","volume":"15","author":"Canney","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2022.04.005_bib25","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.kint.2016.06.020","article-title":"The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseases","volume":"90","author":"Hogan","year":"2016","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ajkd.2022.04.005_bib26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1053\/j.ajkd.2022.04.005_bib27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.2007020156","article-title":"Regional implementation of creatinine measurement standardization","volume":"19","author":"Komenda","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2022.04.005_bib28","series-title":"Treatment of End-Stage Organ Failure in Canada, Canadian Organ Replacement Register, 2009 to 2018: End-Stage Kidney Disease and Kidney Transplants Data Tables. CIHI","year":"2019"},{"issue":"9784","key":"10.1053\/j.ajkd.2022.04.005_bib29","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"10.1053\/j.ajkd.2022.04.005_bib30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1053\/j.ajkd.2022.04.005_bib31","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1053\/j.ajkd.2022.04.005_bib32","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1053\/j.ajkd.2022.04.005_bib33","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"446","key":"10.1053\/j.ajkd.2022.04.005_bib34","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"issue":"10","key":"10.1053\/j.ajkd.2022.04.005_bib35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/sim.4154","article-title":"On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data","volume":"30","author":"Uno","year":"2011","journal-title":"Stat Med"},{"issue":"1","key":"10.1053\/j.ajkd.2022.04.005_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/sim.4026","article-title":"Several methods to assess improvement in risk prediction models: extension to survival analysis","volume":"30","author":"Chambless","year":"2011","journal-title":"Stat Med"},{"issue":"3","key":"10.1053\/j.ajkd.2022.04.005_bib37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/sim.1946","article-title":"Explained randomness in proportional hazards models","volume":"24","author":"O\u2019Quigley","year":"2005","journal-title":"Stat Med"},{"key":"10.1053\/j.ajkd.2022.04.005_bib39","first-page":"1","article-title":"Statistical methods in cancer research: Vol. 2, the design and analysis of cohort studies","volume":"82","author":"Breslow","year":"1987","journal-title":"IARC Sci Publ"},{"issue":"2","key":"10.1053\/j.ajkd.2022.04.005_bib40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3346\/jkms.2017.32.2.231","article-title":"Baseline cardiovascular characteristics of adult patients with chronic kidney disease from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)","volume":"32","author":"Kim","year":"2017","journal-title":"J\u00a0Korean Med Sci"},{"issue":"9","key":"10.1053\/j.ajkd.2022.04.005_bib41","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/clc.23388","article-title":"Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: a retrospective observational study","volume":"43","author":"Xie","year":"2020","journal-title":"Clin Cardiol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263862200703X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263862200703X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:43:38Z","timestamp":1759463018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263862200703X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S027263862200703X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2022.04.005","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2022.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}